Table 5.
Hypertensive population | Initial pharmacologic agents | Level of evidence |
---|---|---|
Non-African Americans (including those with diabetes) |
|
Grade B: Moderate recommendation |
African Americans (including those with diabetes) | Grade B: Moderate recommendation for African Americans with diabetes, Grade C: Weak recommendation |